Comprehensive Analysis of the Relationships Between the Gut Microbiota and Fecal Metabolome in Individuals With Primary Sjogren’s Syndrome by 16S rRNA Sequencing and LC–MS-Based Metabolomics DOI Creative Commons
Li Yang, Xiang Zhao,

Jinmei Zou

и другие.

Frontiers in Immunology, Год журнала: 2022, Номер 13

Опубликована: Май 11, 2022

The gut microbiota has been associated with primary Sjogren’s syndrome (pSS), yet the biological implications of these associations are often elusive. We analyzed fecal through 16S rRNA gene amplification and sequencing in 30 patients pSS 20 healthy controls (HCs); At same time, metabolome was characterized by ultrahigh-performance liquid chromatography–mass spectrometry. In addition, correlation analyses data were performed to identify meaningful associations. found that composition significantly different from HCs. is increased abundances proinflammatory microbes, especially Escherichia-Shigella , decreased anti-inflammatory microbes. Concerning metabolome, a multivariate model 33 metabolites efficiently distinguished cases controls. Through KEGG enrichment analysis, we mainly involved amino acid metabolism lipid metabolism. analysis indicated there certain correlations between patients. an abundance be correlated high levels four (aflatoxin M1, glycocholic acid, L-histidine phenylglyoxylic acid). Our research suggests patients, specific combination changes metabolic states. factor related dysbiosis, which may promote intestinal damage affect

Язык: Английский

Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications DOI Creative Commons
Sonia Facchin, Luisa Bertin, Erica Bonazzi

и другие.

Life, Год журнала: 2024, Номер 14(5), С. 559 - 559

Опубликована: Апрель 26, 2024

The gastrointestinal tract is home to trillions of diverse microorganisms collectively known as the gut microbiota, which play a pivotal role in breaking down undigested foods, such dietary fibers. Through fermentation these food components, short-chain fatty acids (SCFAs) acetate, propionate, and butyrate are produced, offering numerous health benefits host. production absorption SCFAs occur through various mechanisms within human intestine, contingent upon types fibers reaching specific engaged fermentation. Medical literature extensively documents supplementation SCFAs, particularly butyrate, treatment gastrointestinal, metabolic, cardiovascular, gut-brain-related disorders. This review seeks provide an overview dynamics involved gut. Additionally, it will focus on roles promoting metabolic health, well their current therapeutic implications.

Язык: Английский

Процитировано

60

Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases DOI Open Access
Ashkan Rasouli‐Saravani, Kasra Jahankhani,

Shadi Moradi

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2023, Номер 162, С. 114620 - 114620

Опубликована: Март 31, 2023

There is emerging evidence that microbiota and its metabolites play an important role in helath diseases. In this regard, gut has been found as a crucial component influences immune responses well immune-related disorders such autoimmune Gut bacterial dysbiosis shown to cause disease altered metabolite synthesis, leading immunological metabolic dysregulation. Of note, the produce short-chain fatty acids (SCFAs) acetate, butyrate, propionate, remodeling these linked pathophysiology of number type 1 diabetes, multiple sclerosis, inflammatory bowel disease, rheumatoid arthritis, celiac systemic lupus erythematosus. review, we will address most recent findings from noteworthy studies investigating impact SCFAs on various

Язык: Английский

Процитировано

49

The therapeutic potential of dietary intervention: based on the mechanism of a tryptophan derivative-indole propionic acid on metabolic disorders DOI
Ben Niu,

Tong Pan,

Yue Xiao

и другие.

Critical Reviews in Food Science and Nutrition, Год журнала: 2024, Номер unknown, С. 1 - 20

Опубликована: Янв. 8, 2024

Tryptophan (TRP) contributes to individual immune homeostasis and good condition via three complex metabolism pathways (5-hydroxytryptamine (5-HT), kynurenine (KP), gut microbiota pathway). Indole propionic acid (IPA), one of the TRP derivatives pathway, has raised more attention because its impact on metabolic disorders. Here, we retrospect increasing evidence that metabolites/IPA derived from proteolysis host health disease. IPA can activate system through aryl hydrocarbon receptor (AHR) and/or Pregnane X (PXR) as a vital mediator among diet-caused microbe cross-talk. Different levels in systemic circulation predict risk NAFLD, T2DM, CVD. is suggested alleviate cognitive impairment oxidative damage, reduce inflammation, inhibit lipid accumulation attenuate symptoms putatively enhance intestinal epithelial barrier, maintain homeostasis. Now, provide general description relationships between various physiological pathological processes, which support an opportunity for diet intervention diseases.

Язык: Английский

Процитировано

26

Diabetes and gut microbiome DOI Creative Commons
K. Fliegerová, Tiziana Maria Mahayri, Hana Sechovcová

и другие.

Frontiers in Microbiology, Год журнала: 2025, Номер 15

Опубликована: Янв. 7, 2025

Diabetes mellitus represents a significant global health problem. The number of people suffering from this metabolic disease is constantly rising and although the incidence heterogeneous depending on region, country, economic situation, lifestyle, diet level medical care, it increasing worldwide, especially among youths children, mainly due to lifestyle environmental changes. pathogenesis two most common subtypes diabetes mellitus, type 1 (T1DM) 2 (T2DM), substantially different, so each form characterized by different causation, etiology, pathophysiology, presentation, treatment. Research in recent decades increasingly indicates potential role gut microbiome initiation, development, progression disease. Intestinal microbes their fermentation products have an important impact host metabolism, immune system, nutrient digestion absorption, barrier integrity protection against pathogens. This review summarizes current evidence changes microbial populations both types mellitus. Attention focused abundance specific bacterial groups at taxonomic levels humans, shift also assessed relation geographic location, age, antidiabetic drug. causal relationship between bacteria still unclear, future studies applying new methodological approaches broader range microorganisms inhabiting digestive tract are urgently needed. would not only provide better understanding disease, but use beneficial species probiotics for treatment diabetes.

Язык: Английский

Процитировано

4

Cordyceps cicadae polysaccharides ameliorated renal interstitial fibrosis in diabetic nephropathy rats by repressing inflammation and modulating gut microbiota dysbiosis DOI
Junling Yang,

Huibin Dong,

Ya Wang

и другие.

International Journal of Biological Macromolecules, Год журнала: 2020, Номер 163, С. 442 - 456

Опубликована: Июнь 25, 2020

Язык: Английский

Процитировано

84

Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes DOI
Tiantian Zhu, Mark O. Goodarzi

Current Nutrition Reports, Год журнала: 2020, Номер 9(2), С. 83 - 93

Опубликована: Март 9, 2020

Язык: Английский

Процитировано

74

The role of the microbiome in diabetes mellitus DOI Creative Commons
Shi‐Li Zhang,

Yulan Cai,

Chuzhen Meng

и другие.

Diabetes Research and Clinical Practice, Год журнала: 2020, Номер 172, С. 108645 - 108645

Опубликована: Дек. 24, 2020

The microbiome is greatly significant for immune system development and homeostasis. Dysbiosis in gut microbial composition function linked to responses the of metabolic diseases, including diabetes mellitus (DM). However, skin changes diabetic patients their role DM are poorly elucidated. In this review, we summarize recent findings about association between microbiota DM, highlighting roles proinflammatory status DM. Moreover, although there evidence that connection causes same activated innate response, additional studies needed explore mechanism. These might inform future prevention, diagnosis treatment.

Язык: Английский

Процитировано

73

Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes DOI Creative Commons
Tulika Arora, Valentina Tremaroli

Frontiers in Endocrinology, Год журнала: 2021, Номер 12

Опубликована: Окт. 19, 2021

Metagenomics studies have shown that type 2 diabetes (T2D) is associated with an altered gut microbiota. Whereas different microbiota patterns been observed in independent human cohorts, reduction of butyrate-producing bacteria has consistently found individuals T2D, as well those prediabetes. Butyrate produced the large intestine by microbial fermentations, particularly dietary fiber, and serves primary fuel for colonocytes. It also acts histone deacetylase inhibitor ligand to G-protein coupled receptors, affecting cellular signaling target cells, such enteroendocrine cells. Therefore, butyrate become attractive drug treatment strategies devised increase its intestinal levels, example supplementation or through fecal transplant (FMT). In this review, we provide overview current literature indicating these yielded encouraging results short-term benefits humans, but long-term improvements glycemic control not reported so far. Further are required find effective approaches restore levels gut, investigate their impact on glucose regulation T2D.

Язык: Английский

Процитировано

69

Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential DOI Creative Commons

Yanyan Que,

Man Cao,

Jianquan He

и другие.

Frontiers in Immunology, Год журнала: 2021, Номер 12

Опубликована: Авг. 12, 2021

Type 2 diabetes mellitus (T2DM) is a complex disorder comprehensively influenced by genetic and environmental risk, research increasingly has indicated the role of microbial dysbiosis in T2DM pathogenesis. However, studies comparing microbiome characteristics between healthy controls have reported inconsistent results. To further identify describe intestinal flora patients, we performed systematic review meta-analysis stool profiles to discern explore heterogeneity among 7 (600 cases, 543 controls, 1143 samples total). Using random effects model fixed model, observed significant differences beta diversity, but not alpha individuals with controls. We identified various operational taxonomic unit (OTUs) bacterial genera odds ratios for T2DM. The signatures derived from single study stepwise feature selection could be applied other studies. By training on multiple studies, improved detection accuracy disease specificity also discuss relationship T2DM-enriched or T2DM-depleted probiotics provide new ideas prevention improvement.

Язык: Английский

Процитировано

64

Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract DOI
Aline C. Fenneman, Melissa Weidner, Lea Ann Chen

и другие.

Nature Reviews Gastroenterology & Hepatology, Год журнала: 2022, Номер 20(2), С. 81 - 100

Опубликована: Окт. 18, 2022

Язык: Английский

Процитировано

63